Free shipping on all orders over $ 500

STM2457

Cat. No. M11368

All AbMole products are for research use only, cannot be used for human consumption.

STM2457 Structure
Size Price Availability Quantity
1mg USD 90  USD90 In stock
5mg USD 200  USD200 In stock
10mg USD 320  USD320 In stock
25mg USD 600  USD600 In stock
50mg USD 900  USD900 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

STM2457 is a first-in-class, potent and specific, orally active METTL3 inhibitor with an IC50 of 16.9 nM and excellent in vivo activity without off-target effects.

Protocol (for reference only)
Cell Experiment
Cell lines MOLM-13 cells
Preparation method Western blot analysis
Cells were treated with Vehicle (DMSO) or the indicated concentrations of STM2457 and after 72 hours cell pellets resuspended in whole cell lysis buffer (50 mM Tris-HCl pH=8, 450 mM NaCl, 0.1% NP-40, 1mM EDTA), supplemented with 1 mM DTT, protease inhibitors, and phosphatase inhibitors. Protein concentrations were assessed by Bradford assay and an equal amount of protein was loaded per track. Prior to loading, the samples were supplemented with SDS-PAGE sample buffer and DTT was added to each sample. 10-40 μg of protein was separated on SDS-PAGE gels, and blotted onto polyvinylidene difluoride membranes.
Concentrations 1, 5 and 10 μM
Incubation time 72 hours
Animal Experiment
Animal models 6- to 10-week-old NSG female mice
Formulation dissolved in 20%(w/v) 2-hydroxyproply beta-cyclodextrin vehicle
Dosages 50 mg/kg
Administration intraperitoneal injection
Chemical Information
Molecular Weight 444.53
Formula C25H28N6O2
CAS Number 2499663-01-1
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Xia Wu, et al. Front Oncol. The Role of RNA Methyltransferase METTL3 in Normal and Malignant Hematopoiesis

[2] Shu Fang, et al. Front Genet. Transcriptome-Wide Analysis of RNA N 6-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia Cells

[3] Qiong-Cong Xu, et al. Oncogene. METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m 6 A-YTHDF2-dependent manner

[4] Eliza Yankova, et al. Nature. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia

Related METTL3 Products
UZH1a

UZH1a is a potent and selective METTL3 inhibitor, with an IC50 of 280 nM. UZH1a can be used for epitranscriptomic modulation of cellular processes. UZH1a has antitumor activity.

METTL3-IN-4

METTL3-IN-4 is a METTL3 inhibitor.

STM2120

STM2120 is a METTL3-METTL14 inhibitor with an IC50 of 64.5 μM.

7OQL

7OQL is a selective METTL3 inhibitor (IC50=0.054 µM).

STC-15

STC-15 is a METTL3 inhibitor used in the study of proliferative diseases such as cancer and autoimmune diseases.

  Catalog
Abmole Inhibitor Catalog




Keywords: STM2457 supplier, METTL3, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.